The effect on stone expulsive rate and the safety of Tadarafil in urolithiasis patients.
- Conditions
- rolithiasis
- Registration Number
- JPRN-UMIN000021468
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Not provided
1)patients taking alpha1 receptor blocker 2)patients taking anti cholinergic agents 3)patients taking steroidal agents 4)pregnant women 5)patients with multiple ureteral stones 6)patients treated with NO donor 7)patients treated with Riociguat 8)patients with unstable angina, heart failure (over NYHA grade III), uncontrolled arrhythmia, hypotension (<90/50mmHg), uncontrolled hypertension (>170/100mmHg), cardiac infarction within last three months, cerebral hemorrhage /infarction with in last six months 9)patients with severe renal failure 10)patients with severe liver failure 11)patients cannot visit hospital for evaluation 12)others that decided inapplicable by principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method